[INM] YoY Quarter Result on 31-Dec-2023 [#Q2]

Stock
[INM] InMed Pharmaceuticals Inc.
Announcement Date
13-Feb-2024
Financial Year
2024
Quarter
31-Dec-2023 [#Q2]
Profit Trend
QoQ- 41.74%
YoY- 29.65%
Quarter Report
INM's Result
INM's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 1,240 470 265 0 0 0 0 -
PBT -1,478 -2,098 -4,283 -2,244 -2,565 -1,948 -1,228 3.13%
Tax -227 3 22 360 -13 -197 -2 119.95%
NP -1,478 -2,101 -4,283 -2,244 -2,565 -1,948 -1,228 3.13%
Tax Rate - - - - - - - -
Total Cost 2,718 2,571 4,548 2,244 2,565 1,948 1,228 14.15%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -119.19 -447.25 -1,615.60 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.19 -0.91 -7.73 -9.21 -12.28 -9.41 -7.64 -45.95%
EPS Diluted -0.19 -0.91 -7.73 -9.21 -12.28 -9.41 -7.64 -45.95%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.